Skip to main content
. 2015 Winter;19(1):38–43. doi: 10.7812/TPP/14-010

Table 4.

Demographics and medical history in relation to invasive pneumococcal disease

Factor Cases (n = 171) No. (%) Controls (n = 342) No. (%) Odds ratioa (95% CI)
Demographic
  Male sex 83 (49) 184 (54) 0.84 (0.58–1.22)
  Nonwhite raceb 34 (20) 19 (6) 4.37 (2.32–8.22)
Chronic conditions
  High-risk for IPD c 18 (11) 24 (7) 1.51 (0.77–2.94)
  Chronic asthma 13 (8) 22 (6) 1.18 (0.57–2.45)
  Pneumococcal vaccination 11 (6) 26 (8) 0.49 (0.12–2.03)
Diagnoses/events at visit < 3 months before reference date
  Antibiotic use 66 (39) 97 (28) 1.57 (1.06–2.33)
  Ophthalmologic ICD-9 10 (6) 22 (6) 0.92 (0.42–1.99)
  ENT ICD-9 76 (44) 128 (37) 1.33 (0.92–1.93)
  Otitis media 46 (27) 81 (24) 1.20 (0.78–1.84)
  Nonotitis media ENT ICD-9 30 (18) 47 (14) 1.34 (0.80–2.23)
  Pulmonary ICD-9 24 (14) 23 (7) 2.20 (1.20–4.02)
  Gastrointestinal ICD-9 19 (11) 21 (6) 1.81 (0.96–3.41)
  Genitourinary ICD-9 6 (4) 7 (2) 1.77 (0.58–5.41)
  Musculoskeletal ICD-9 5 (3) 6 (2) 1.59 (0.48–5.23)
  Skin disease ICD-9 11 (6) 46 (13) 0.45 (0.22–0.90)
  Neurologic ICD-9 4 (2) 10 (3) 0.79 (0.24–2.61)
  Systemic disease ICD-9 8 (5) 10 (3) 1.69 (0.62–4.61)
  Any infectious disease 85 (50) 146 (43) 1.33 (0.92–1.92)
  Infectious disease: viral ICD-9 14 (8) 21 (6) 1.33 (0.65–2.72)
  Infectious disease: fungal ICD-9 1 (1) 4 (1) 0.52 (0.06–4.70)
  Infectious disease: bacterial ICD-9 5 (3) 5 (1) 1.80 (0.51–6.34)
a

Conditional logistic regression odds ratios adjusted for patterns of Health Plan membership.

b

Subjects with missing data on race (25% of cases and 51% of controls) were considered as white in this analysis.

c

Includes asthma, chronic cardiac disease, chronic pulmonary disease, diabetes mellitus, immune deficiency, sickle cell anemia, cancer, chronic kidney disease, functional/anatomic asplenia, cerebrospinal fluid leak, and cystic fibrosis.

CI = confidence interval; ENT = ear/nose/throat; ICD-9 = International Classification of Diseases, Ninth Revision; IPD = invasive pneumococcal disease.